相关实验视频

Updated: May 23, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

基于mRNA的cGAS免疫激动剂促进疫苗反应和抗瘤免疫力

Yali Qu^1,2, Zhibin Li^2,3, Jiahao Yin^1,2

¹National Key Laboratory of Immune Response and Immunotherapy, Department of General Surgery, The First Affiliated Hospital of University of Science and Technology of China, Center for Advanced Interdisciplinary Science & Biomedicine IHM, Division of Life Sciences & Medicine, University of Science and Technology of China, Hefei, China.

Cancer immunology research

|March 11, 2025

概括

研究人员使用脂质纳米粒子 (LNP) 开发了一种基于cGAS mRNA的新型辅助剂. 这种强大的辅助剂增强了疫苗的疗效,并刺激了抗瘤免疫力,为癌症免疫疗法提供了新的策略.

科学领域:

免疫学免疫学免疫学
疫苗学疫苗学疫苗学
分子生物学分子生物学

背景情况:

使者RNA (mRNA) 疫苗对免疫有效,但缺乏增强免疫反应的辅助剂.
辅助剂对于提高疫苗对病毒性疾病和癌症的疗效至关重要.

研究的目的:

开发一种使用循环GMP-AMP合成酶 (cGAS) mRNA与脂质纳米粒子 (LNP) 复合的新型辅助剂.
增强免疫反应和疫苗功效,特别是用于癌症免疫疗法.

主要方法:

改造的人类cGAS mRNA (hcGASK187N/L195R),具有增加cGAS活性的特定突变.
复合了修改后的mRNA与LNP,以创建cGAS mRNA-LNP.
在体外和体内评估辅助作用,评估免疫细胞激活和疫苗强化.

主要成果:

突变的cGAS mRNA-LNP显著增强了STING介导的IFN反应.
证明了抗原呈现细胞功能的强化和放大了幽默和细胞介导免疫力.
通过IFNγ表现出显著的抗瘤免疫力和直接通过IFNγ限制瘤细胞.

结论:

开发了一种基于cGAS mRNA的免疫刺激辅助剂,与各种疫苗平台兼容.
辅助剂有效地提高了自适应性免疫反应,并增强了癌症免疫疗法.
这种方法为提高疫苗疗效和癌症治疗提供了一个有希望的策略.

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...